Cure8

Why This Matters

ITB can closely mimic Crohn’s disease, so this study is relevant because it describes diagnostic test yields and illustrates that targeted TB testing and therapeutic trials of antituberculosis treatment can help distinguish ITB from CD.

Who Should Pay Attention

Clinicians evaluating suspected Crohn’s disease, gastroenterologists, infectious disease specialists, researchers studying differential diagnosis of intestinal inflammatory diseases, and adult patients undergoing evaluation for Crohn-like symptoms.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This retrospective single-center series (2012–2025) reviewed 46 patients with ITB. Abdominal pain was the most common symptom. The authors report positive rates for T-SPOT.TB (81.25% overall, 100% in the six misdiagnosed patients tested) and PPD (40.91% overall, 50% in the misdiagnosed subgroup), and note only partial concordance between tests.

Because ITB can mimic CD on endoscopy and imaging, the study describes using diagnostic antituberculosis therapy as an auxiliary diagnostic approach in patients where ITB could not be excluded; the six initially misdiagnosed patients reportedly improved with antituberculosis treatment.

Clinical takeaways The paper’s main practical point is that physicians should maintain suspicion for intestinal tuberculosis in patients with Crohn-like findings, use targeted TB testing (T-SPOT.TB and PPD) and chest imaging, and consider diagnostic antituberculosis therapy when uncertainty remains. This may reduce misdiagnosis and improve outcomes.

Keep In Mind

This is a retrospective, single-center case series using data from 2012–2025 and the content depth is an abstract-based summary of the article. Findings reflect the tested cohort and diagnostic practices at that center; diagnostic yields may differ by TB prevalence, test availability, and local practice.

The article describes use of diagnostic antituberculosis therapy as an adjunct to diagnosis rather than as a proven definitive test.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationFrontiers in Medicine
PublisherFrontiers Media SA
AuthorsLin Li, Jing Wang, Xiaoping Niu
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 10, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →